申请人:Japan Tobacco Inc.
公开号:EP0603419A1
公开(公告)日:1994-06-29
A novel thiazolidinedione compound represented by general formula (I), a pharmaceutically acceptable salt thereof, and a pharmaceutical composition thereof; wherein R represents an aromatic, cycloaliphatic or heteroaromatic hydrocarbon group which may be substituted; R₁ and R₂ represent each independently hydrogen, lower alkyl, or an aromatic or heteroaromatic hydrocarbon group which may be substituted by lower alkyl, acyl, lower alkoxy, cyano, nitro, lower alkoxycarbonyl or sulfonyl; R₃ represents hydrogen, hydroxy, lower alkyl, acyl, lower alkoxy, cyano, nitro, lower alkoxycarbonyl or sulfonyl; R₄ represents lower alkyl; X represents oxygen, sulfur or sec. amino; A represents (CH₂)m (wherein m is an integer of 0, 1, or 2); and B represents (CH₂)n (wherein n is an integer of 0, 1 or 2). This compound is excellent in hypoglycemic and hypolipemic effects, so that it is useful for treating diabetes, preventing and treating the complications of diabetes, and treating hyperlipemia.
一种由通式(I)代表的新型噻唑烷二酮化合物、其药学上可接受的盐及其药物组合物;其中 R 代表可被取代的芳族、环脂族或杂芳族烃基;R₁和 R₂ 各自独立地代表氢、低级烷基或可被低级烷基、酰基、低级烷氧基、氰基、硝基、低级烷氧羰基或磺酰基取代的芳香族或杂芳族烃基; R₃ 代表氢、羟基、低级烷基、酰基、低级烷氧基、氰基、硝基、低级烷氧羰基或磺酰基; R₄ 代表低级烷基; X 代表氧、硫或仲烷基; A 代表 (CH₄)氨基;A 代表 (CH₂)m(其中 m 为 0、1 或 2 的整数);B 代表 (CH₂)n(其中 n 为 0、1 或 2 的整数)。该化合物具有良好的降血糖和降血脂作用,因此可用于治疗糖尿病、预防和治疗糖尿病并发症以及治疗高脂血症。